ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for GrowthBusiness Wire • 10/01/21
ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland ChinaBusiness Wire • 09/29/21
ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP™)Business Wire • 09/20/21
ChromaDex Continues to Defend Strong Intellectual Property Portfolio and Plans to Appeal Judge's Ruling in Patent Infringement LawsuitBusiness Wire • 09/15/21
ChromaDex Corporation (CDXC) CEO Rob Fried on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
ChromaDex to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021Business Wire • 07/20/21
CHROMADEX'S HEALTHY AGING PRODUCTS GAIN NEW TRACTION WITH FOUR HUGE DISTRIBUTION AGREEMENTS INCLUDING WALMARTBenzinga • 06/16/21
ChromaDex Shares Research Findings from the ChromaDex External Research Program (CERP™)Business Wire • 06/16/21
ChromaDex and Walmart Launch Tru Niagen® in 3,800 Walmart Stores Across the United StatesBusiness Wire • 06/07/21
ChromaDex (CDXC) CEO Robert Fried on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021Business Wire • 04/29/21
ChromaDex and Health & Happiness (H&H) Group Announce Supply Agreement for Niagen®Business Wire • 04/28/21